2019
DOI: 10.22452/jummec.vol22no1.4
|View full text |Cite
|
Sign up to set email alerts
|

Safety and Efficacy of Two Tacrolimus Formulations (Prograf® and Advagraf®) in Malaysian Renal Transplant Patients: A Comparative Study

Abstract: Aim: A once-daily formulation of tacrolimus, Advagraf®, is increasingly being used in place of twice-daily tacrolimus, Prograf®, as a standard immunosuppressive agent for transplant patients. In this study, the clinical safety and efficacy of Advagraf® were compared with Prograf®, among multi-ethnic Malaysian renal transplanted population. Method: This retrospective study identified renal transplant patients who were converted from Prograf ® to Advagraf ® at the University Malaya Medical Centre (UMMC) (n=69). … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 23 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?